^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Columvi (glofitamab-gxbm)

i
Other names: RG6026, RO7082859, CD20 TCB, RG 6026, RO-7082859, RO 7082859, anti-CD20 CD3 TCB
Company:
Biogen, Roche
Drug class:
CD20 inhibitor, CD3 agonist
Related drugs: